Related references
Note: Only part of the references are listed.Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen
Carole Ayoub Moubareck et al.
ANTIBIOTICS-BASEL (2020)
Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis
Adrian Schmid et al.
SCIENTIFIC REPORTS (2019)
In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran
Raziyeh Kheshti et al.
INFECTION AND DRUG RESISTANCE (2019)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Sulbactam enhances the in vitro activity of sitafloxacin against extensively-drug resistant Acinetobacter baumannii
Nannan Xu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
I-Ling Cheng et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
Sombat Leelasupasri et al.
JOURNAL OF PATHOGENS (2018)
Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model
Wenjuan Wei et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2017)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Few novel antibiotics in the pipeline, WHO warns
Zosia Kmietowicz
BMJ-BRITISH MEDICAL JOURNAL (2017)
Few novel antibiotics in the pipeline, WHO warns
Zosia Kmietowicz
BMJ-BRITISH MEDICAL JOURNAL (2017)
Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains
Li-Kuang Chen et al.
SCIENTIFIC REPORTS (2017)
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
Gyun Cheol Park et al.
ANNALS OF LABORATORY MEDICINE (2016)
A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii
Gabriel A. March et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2015)
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
Keith S. Kaye et al.
PHARMACOTHERAPY (2015)
Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin
A. Safarika et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
Michael Hornsey et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Doo Ryeon Chung et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Sitafloxacin In Bacterial Infections
Gillian M. Keating
DRUGS (2011)
In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii
K. C. Guelfi et al.
JOURNAL OF CHEMOTHERAPY (2008)
Multildrug-resistant Acinetobacter infection mortality rate and length of hospitalization
Rebecca H. Sunenshine et al.
EMERGING INFECTIOUS DISEASES (2007)
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
F Timurkaynak et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa
George G. Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping
S Brisse et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2000)
Share Paper
